Skip to main content

Table 1 ADA 2007 Treatment Recommendations [3]

From: A practical approach for implementation of a basal-prandial insulin therapy regimen in patients with type 2 diabetes

Glycemic control:

 

A1C

< 7.0%*†

Preprandial glucose or FPG

90–130 mg/dL

Peak postprandial capillary plasma glucose

< 180 mg/dL

Keypoints:

 

• Goals should be individualized

 

• Special populations may require treatment modifications

 

• If A1C goals are not met despite reaching preprandial glucose goals, target treatment to PPG goals if home glucose monitoring data demonstrate abnormally high blood glucose levels

 
  1. *Referenced to a nondiabetic range of 4.0%–6.0% using a Diabetes Control and Complications
  2. Trial-based assay.
  3. †More stringent glycemic goals (ie, a normal A1C < 6.0%) may further reduce complications at the cost of increased hypoglycemia risk.
  4. Copyright © 2007 American Diabetes Association from Diabetes Care, Vol. 30, 2007; S4-S41 Modified with permission from The American Diabetes Association
Back to article page

Osteopathic Medicine and Primary Care

ISSN: 1750-4732